Medscape InDiscussion: Advanced and Metastatic Breast Cancer

Drs Banu Arun and Avan J. Armaghani discuss the evolving treatment landscape of targeted therapy for advanced and metastatic breast cancer, including risk factors, quality of life, and treatment access. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982651). The topics and discussions are planned, produced, and reviewed independently...

Drs Banu Arun and Stephanie Graff discuss drug access, clinical trials, and health disparities in advanced and metastatic breast cancer, and inclusion-based solutions for physicians and institutions. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982650). The topics and discussions are planned, produced, and reviewed independently of...

Drs Banu Arun and Hope S. Rugo discuss immunotherapy, immunotoxicity, and comorbidities among diverse patient populations in advanced and metastatic breast cancer. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982649). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intend...

Drs Banu Arun and Kevin Kalinsky discuss immunotherapy in the treatment of advanced and metastatic breast cancer, including recent studies, side effects, access to treatment, and disparities in care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982648). The topics and discussions are planned, produced, and reviewed independently of...

Drs Banu Arun and Nadine Tung discuss access to genetic counseling and germline genetic testing, and their earlier incorporation into the multidisciplinary management of patients with breast cancer. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982646). The topics and discussions are planned, produced, and reviewed independently of...

Drs Banu Arun and Filipa Lynce discuss what the future holds for antibody-drug conjugates in different metastatic breast cancer subgroups, including efficacy, strategies, and toxicities. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982644). The topics and discussions are planned, produced, and reviewed independently of advertisers....